#HDAC
Drug discovery digest, Nov 14 — 28 new articles:
• Blackstone commits up to $1.5B to fund Pfizer’s monthly obesity shot through Phase 3
• Dual SIRT6/HDAC inhibitor S20 targets pancreatic cancer metastasis

#DrugDiscovery #MedChem #ChemSky #BioSky #Biotech
Daily digest — 2026-11-14 | The Pharma Digest
Today's 28 articles span HDAC and peptide-degrader chemistry, six Science Translational Medicine studies, computational audits of ML benchmarks, and industry news led by Blackstone's $1.5B Pfizer obesity financing and Bristol Myers' R&D merger.
pharmadigest.net
November 14, 2026 at 12:48 PM
We show that histone deacetylase (HDAC) inhibition with Trichostatin A can attenuate muscle deterioration during mechanical unloading, improve mobility, broadly counteract atrophy-associated gene expression, and partially preserve chromatin architecture.
November 10, 2026 at 4:23 PM
HDAC + PARP inhibitor boosted #HIV latency reversal ~3-fold and cut the latent #reservoir by 67% in HIVGR670-infected primary CD4 T cells. Talazoparib also enhanced NK killing in vitro—a dual "kick and kill" strategy built on FDA-approved drugs.
👇
www.mdpi.com/1999-4915/17...
November 13, 2026 at 2:31 AM
Dual HDAC6 and HDAC8 inhibition enhances STING mediated innate immune responses
This work was supported by the Basic Science Research Program (2023R1A2C1007899 to J.P., RS-2023-00211336 and RS-2021-NR060140 to J.K.) and the Priority Research Institute Program (RS-2023-00271205 to J.P.) through the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning. This work was also supported by Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) grant (2019R1A6C1010006 to J.P.), Global-Learning & Academic research institution for Master’s·PhD students, and Postdocs (G-LAMP) program (RS-2023-00301850 to J.P., RS-2025-25441317 to J.K.) from the Ministry of Education, South Korea, Korea Institute of Science and Technology (KIST) Institutional Program (26E0143, 26V0140, 26V0200, and 26Z9082 to S.L.), Korea US Collaboration Research Fund (KUCRF) funded by the Ministry of Science and ICT and Ministry of Health & Welfare (RS-2024-00467483 to S.L.). Moreover, this study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (RS-2023-00254795, RS-2026-25538024, and RS-2026-25528645 to S.L.). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s)...
www.nature.com
November 14, 2026 at 6:48 AM
HDAC8 Antibody Market Report | In-Depth Market Analysis 2035 | WiseGuyReports www.wiseguyreports.com/reports/hdac...
HDAC8 Antibody Market Report | In-Depth Market Analysis 2035
HDAC8 Antibody Market is Estimated to Reach a Valuation of USD 800 Billion by 2035, Growing at a CAGR of 5.9% During the Forecast Period 2026 - 2035 | Wiseguy Reports
www.wiseguyreports.com
November 10, 2026 at 8:08 AM
A conformation-sensitive product inhibitor of HDAC1/2 potentiates WNT signaling
Maurice, M. M. & Angers, S. Mechanistic insights into WNT–β-catenin pathway activation and signal transduction. Nat. Rev. Mol. Cell Biol. 26, 371–388 https://doi.org/10.1038/s41580-024-00823-y (2025). Nusse, R. & Clevers, H. WNT/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985–999 https://doi.org/10.1016/j.cell.2017.05.016 (2017). Choi, B. Y. Targeting WNT/β-catenin pathway for developing therapies for hair loss. Int. J. Mol. Sci. 21, 4915 https://doi.org/10.3390/ijms21144915 (2020). Regazzetti, C. et al. Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients. J. Invest. Dermatol. 135, 3105–3114 https://doi.org/10.1038/jid.2015.335 (2015). Wang, T. et al. Lgr5+ cells regenerate hair cells via proliferation and direct transdifferentiation in damaged neonatal mouse utricle. Nat. Commun. 6, 6613 https://doi.org/10.1038/ncomms7613 (2015). Post, Y. et al. Design principles and therapeutic applications of novel synthetic WNT signaling agonists. iScience 27, 109938 https://doi.org/10.1016/j.isci.2024.109938 (2024). Cong, F., Cheung, A. K. & Huang, S. M. Chemical genetics-based target identification in drug discovery. Annu. Rev. Pharmacol. Toxicol. 52, 57–78 https://doi.org/10.1146/annurev-pharmtox-010611-134639 (2012). Huang, S. M. et al. Tankyrase inhibition stabilizes axin and antagonizes WNT signalling. Nature 461, 614–620 (2009). Dioum, E. M. et al. A small molecule differentiation inducer increases insulin production by pancreatic β cells. Proc. Natl Acad. Sci. USA 108, 20713–20718...
www.nature.com
November 12, 2026 at 6:15 AM
Epigenetics Update - Histone deacetylase inhibition induces an antitumor IRF8-dependent trained immunity-like status in macrophages www.nature.com/articles/s41...

#Epigenetics #HDAC #Immunity #Cancer #IRF8 #Macrophages
---

Discover the breakthrough at epigenometech.com
October 29, 2026 at 7:46 AM
He showed that HDAC (histone deacetylase enzymes) were overactive in Duchenne patients and animal models, due to a misregulation of NO signaling, due to the absence of dystrophin (which normally links the enzyme making NO, nNOS, to the membrane).
October 29, 2026 at 10:39 AM
Progression-free survival in unresectable melanoma improved significantly with the addition of an investigational HDAC inhibitor to immunotherapy, a randomized trial showed. #ESMO26 https://www.medpagetoday.com/meetingcoverage/esmo/123607
Novel HDAC Inhibitor Hits Main Goal in Unresectable Melanoma Trial
Four-month gain in PFS with HBI-8000, 13 months in LDH-normal subgroup, but toxicity a concern
www.medpagetoday.com
October 28, 2026 at 1:24 PM
Happy to see the last piece of my PhD work at @crg.eu in @maradierssen.bsky.social's lab out published.
www.cell.com/iscience/ful...
HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
Genetics; Molecular biology; Developmental biology
www.cell.com
October 26, 2026 at 2:13 PM
Thank you for citing #tidyplots 🙏

Kaidi Guo et al. HDAC Inhibitors Potentiate Doxorubicin Cytotoxicity in HepG2 Cells and Alter DNA-Repair- and p53-Associated Transcriptional Programs. International Journal of Molecular Sciences (2026).

doi.org/10.3390/ijms...

#rstats #dataviz #phd
October 21, 2026 at 7:35 PM
Relapsed or refractory #DLBCL remains difficult to treat after multiple therapies.
A phase 2 study found that dual #HDAC/PI3Kα inhibition with ifupinostat produced clinical responses, alongside substantial hematologic toxicity.
#STTT #OpenAccess: doi.org/10.1038/s413...
October 21, 2026 at 12:45 PM
Can #CUDC907 improve #glioblastoma treatment?
This dual PI3K/HDAC inhibitor suppresses tumor growth and migration and enhances temozolomide sensitivity by disrupting cell-cycle regulation and #DNAdamage repair.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
October 20, 2026 at 2:30 PM
Cai et al. develop Swap-seq, pairing pooled twin prime editing with flow sorting to delete hundreds of regulatory elements at PPIF in THP-1 monocytes, quantifying enhancers and CTCF insulators and uncovering an HDAC-dependent silencer that represses neighboring enhancers.
bioRxiv (All)
www.biorxiv.org
October 10, 2026 at 12:22 PM
The authors included RRIDs in their in Cell Death & Disease paper! RRIDs improve reproducibility in scientific research. #RRID #BetterScience #OpenResearch
Loss of FAM60A disrupts Sin3/HDAC control of the Hippo signaling and promotes oncogenic YAP1 activation - Cell Death & Disease
Read the full paper: Loss of FAM60A disrupts Sin3/HDAC control of the Hippo signaling and promotes oncogenic YAP1 activation
doi.org
October 10, 2026 at 7:00 AM
So how does s1 work? It appears to be an HDAC-dependent silencer that can be inhibited by drugs, e.g. TMP269. Deleting it endogenously led to significant increases of H3K27ac at neighboring accessible peaks within 30 kb — it locally represses nearby enhancers to regulate distal genes (Model 5✅).
October 9, 2026 at 4:50 PM
The authors included RRIDs in their in Advanced Science paper! We value the author's support of reproducibility. #methodsmatter #BetterScience #accelerateopenscience
ROS‐Responsive Nanoparticle Delivery of Dexmedetomidine Protects the Gut Vascular Barrier After Intestinal Ischemia/Reperfusion via the HDAC‐H3K27ac‐TCF4 Axis
Read the full paper: ROS‐Responsive Nanoparticle Delivery of Dexmedetomidine Protects the Gut Vascular Barrier After Intestinal Ischemia/Reperfusion via the HDAC‐H3K27ac‐TCF4 Axis
doi.org
October 8, 2026 at 7:06 AM
Combined HDAC and ATM inhibition with radiation in preclinical glioblastoma models https://www.biorxiv.org/content/10.64898/2026.10.06.756776v1
October 7, 2026 at 2:47 PM
Combined HDAC and ATM inhibition with radiation in preclinical glioblastoma models https://www.biorxiv.org/content/10.64898/2026.10.06.756776v1
October 7, 2026 at 2:47 PM
HDAC inhibitors certainly are interesting. Unshielding DNA, causing gene chaos, certainly a two if not a 3 hit scenario if you include oxidative stress.

I wonder what other things achieve this unshielding.

#Exposome
October 6, 2026 at 7:12 PM
The authors included RRIDs in their in iScience paper! Thanks for making your methods matter! #OpenResearch #methodsmatter #RRID
HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
Read the full paper: HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
doi.org
October 2, 2026 at 7:01 AM